Form 4: Astera Labs Director Receives Restricted Stock Unit Grant
Insider Transaction Report
Astera Labs, Inc. Director Stefan A Dyckerhoff was granted 2,351 restricted stock units, vesting over the next year, as part of the company's 2024 Stock Option and Incentive Plan.
Summary
- Stefan A Dyckerhoff, a Director of Astera Labs, Inc. (ALAB), was granted 2,351 shares of common stock in the form of Restricted Stock Units (RSUs) on June 8, 2025.
- These RSUs were granted under the Astera Labs, Inc. 2024 Stock Option and Incentive Plan at a price of $0 per share.
- The award vests in full upon the earlier of June 8, 2026 (the first anniversary of the grant date) or the date of the next annual stockholder meeting following the grant date, contingent on continuous service.
- Following this transaction, Mr. Dyckerhoff directly beneficially owns 124,154 shares of Common Stock.
- Additionally, Mr. Dyckerhoff indirectly beneficially owns 392,028 shares through various entities: 9,936 shares via a limited partnership, 364,064 shares via a trust, and 3,767, 3,765, 3,765, 3,765, and 3,765 shares via five different irrevocable trusts (DIFT-2, DIFT-AMD, DIFT-BAD, DIFT-SHD, DIFT-IND).
Sentiment
Score: 7
Explanation: The grant of Restricted Stock Units to a director is a positive event, aligning management incentives with shareholder interests and indicating continued commitment. It's a routine compensation event, hence not extremely high on the scale, but certainly not negative.
Positives
- Grant of 2,351 Restricted Stock Units (RSUs) to a Director, indicating continued alignment of management interests with shareholder value.
- The RSUs were granted at a price of $0, representing a direct equity award.
- The vesting schedule encourages long-term commitment from the director.
Future Outlook
The vesting schedule of the RSUs indicates a future commitment of the director to the company's performance and long-term value creation.
Industry Context
This is a standard equity compensation practice for directors in publicly traded technology companies, aligning their interests with long-term shareholder value.
Comparison to Industry Standards
- The grant of Restricted Stock Units (RSUs) to directors is a common practice in the technology sector, including companies like NVIDIA, AMD, and Intel, to incentivize long-term performance and retention.
- The vesting schedule, typically over one to three years or tied to annual meetings, is also standard for such awards, ensuring continued service.
- The grant price of $0 for RSUs is typical, as they represent a contingent right to receive shares upon vesting, unlike stock options which have an exercise price.
Stakeholder Impact
- Shareholders: Minor potential dilution from the issuance of new shares upon RSU vesting, but generally viewed positively as it aligns director incentives with shareholder value.
Next Steps
- Vesting of the 2,351 Restricted Stock Units (RSUs) on the earlier of June 8, 2026, or the date of the next annual stockholder meeting, subject to continuous service.
Key Dates
| Date | Description |
|---|---|
| 06/08/2025 | Grant Date of 2,351 Restricted Stock Units (RSUs) to Director Stefan A Dyckerhoff. |
| 06/10/2025 | Date of filing of the Form 4 statement. |
| 06/08/2026 | Earliest potential vesting date for the 2,351 RSUs (first anniversary of grant date), subject to continuous service. |
| Next Annual Stockholder Meeting after 06/08/2025 | Alternative potential vesting date for the 2,351 RSUs, if earlier than the first anniversary of the grant date, subject to continuous service. |
Recommendation
holdKeywords
Astera Labs, ALAB, Form 4, SEC filing, insider transaction, restricted stock units, RSU, equity compensation, director compensation, beneficial ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.